Literature DB >> 25594137

Association between pulse pressure and risk of hospital admissions for cardiovascular events among people with Type 2 diabetes: a population-based case-control study.

D Yu1, D Simmons1.   

Abstract

AIM: To investigate the association between pulse pressure and risk of hospitalization for cardiovascular events among people with Type 2 diabetes.
METHODS: A population-based case-control study was carried out using data from medical databases. A total of 588 people with Type 2 diabetes from 18 general practices in Cambridgeshire recorded a first hospitalization for a cardiovascular event between 2009 and 2011, and a total of 2920 age-matched, gender-matched and practice-matched control subjects with Type 2 diabetes were selected based on risk-set sampling. Pulse pressure was assessed before admission in 2008-2009. Further dose-response relationships between pulse pressure and risks were explored using spline models.
RESULTS: There was a non-linear relationship between pulse pressure and the risk of hospitalization for a cardiovascular event (P < 0.001 for linearity test). The pulse pressure associated with the lowest risk of hospitalization for a cardiovascular event was 61 (95% CI 57-63) mmHg.
CONCLUSION: In people with Type 2 diabetes, pulse pressure is a good predictor of risk of hospitalization for cardiovascular events. The risk is lowest with a pulse pressure of 57-63 mmHg.
© 2015 The Authors. Diabetic Medicine © 2015 Diabetes UK.

Entities:  

Mesh:

Year:  2015        PMID: 25594137     DOI: 10.1111/dme.12693

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Association between pulmonary function and renal function: findings from China and Australia.

Authors:  Dahai Yu; Tao Chen; Yamei Cai; Zhanzheng Zhao; David Simmons
Journal:  BMC Nephrol       Date:  2017-05-01       Impact factor: 2.388

2.  The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study.

Authors:  Jin Shang; Dahai Yu; Yamei Cai; Zheng Wang; Bin Zhao; Zhanzheng Zhao; David Simmons
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

3.  Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study.

Authors:  Dahai Yu; Zhanzheng Zhao; David Simmons
Journal:  Cardiovasc Diabetol       Date:  2020-10-10       Impact factor: 9.951

4.  Consumption of melatonin supplement improves cardiovascular disease risk factors and anthropometric indices in type 2 diabetes mellitus patients: a double-blind, randomized, placebo-controlled trial.

Authors:  Hadi Bazyar; Ahmad Zare Javid; Hossein Bavi Behbahani; Fardin Moradi; Bahman Moradi Poode; Parichehr Amiri
Journal:  Trials       Date:  2021-03-25       Impact factor: 2.279

5.  Development and validation of risk prediction models for cardiovascular mortality in Chinese people initialising peritoneal dialysis: a cohort study.

Authors:  Dahai Yu; Yamei Cai; Ying Chen; Tao Chen; Rui Qin; Zhanzheng Zhao; David Simmons
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

6.  Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

Authors:  R Chilton; I Tikkanen; C P Cannon; S Crowe; H J Woerle; U C Broedl; O E Johansen
Journal:  Diabetes Obes Metab       Date:  2015-10-09       Impact factor: 6.577

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.